These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26008840)

  • 1. India tackles vaccine preventable diseases.
    Bagcchi S
    Lancet Infect Dis; 2015 Jun; 15(6):637-8. PubMed ID: 26008840
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies for decision-making on vaccine use: the French experience.
    Loulergue P; Floret D; Launay O
    Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A statement regarding personal belief exemption from immunization mandates: from the Pediatric Infectious Diseases Society, March 2011.
    Pediatr Infect Dis J; 2011 Jul; 30(7):606-7. PubMed ID: 21673549
    [No Abstract]   [Full Text] [Related]  

  • 4. Introducing new vaccines into the South African national immunisation programme - a case study.
    Schoub BD; Mphahlele MJ; Ngcobo NJ; Hoosen AA; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C1-2. PubMed ID: 22939014
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine preventable diseases in eastern Maharashtra--a hospital based analysis.
    Rao SP; Bharambe MS
    Indian Pediatr; 1991 Jun; 28(6):629-33. PubMed ID: 1748511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult immunization in India: Importance and recommendations.
    Verma R; Khanna P; Chawla S
    Hum Vaccin Immunother; 2015; 11(9):2180-2. PubMed ID: 25483654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005.
    Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence G; Wood J; Wood N; Rosewell A; Newall A; MacIntyre R; Macartney K; Gidding H; McIntyre P; Booy R
    Commun Dis Intell Q Rep; 2007 Jun; 31 Suppl():S1-152. PubMed ID: 17844780
    [No Abstract]   [Full Text] [Related]  

  • 8. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases.
    Commun Dis Intell Q Rep; 2004; 28(1):92-5. PubMed ID: 15072163
    [No Abstract]   [Full Text] [Related]  

  • 9. Extent of occurrence of the six vaccine preventable diseases in vaccinated/unvaccinated children.
    Singh H; Raizada N; Jain BK; Bhatia RC
    Indian Pediatr; 1991 Jun; 28(6):635-9. PubMed ID: 1748512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of social determinants on immunization programs.
    Glatman-Freedman A; Nichols K
    Hum Vaccin Immunother; 2012 Mar; 8(3):293-301. PubMed ID: 22327490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
    Andrus JK; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of national immunization schedule on vaccine preventable diseases: a hospital based study.
    Choudhury P; Prajapati NC; Puri RK; Sachdev HP
    Indian Pediatr; 1992 Jan; 29(1):33-8. PubMed ID: 1601493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2004; 28(4):490-2. PubMed ID: 15747426
    [No Abstract]   [Full Text] [Related]  

  • 14. The imperative of vaccination.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2017 Nov; 17(11):1099. PubMed ID: 29115253
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.
    Richter D; Anca I; André FE; Bakir M; Chlibek R; Čižman M; Mangarov A; Mészner Z; Pokorn M; Prymula R; Salman N; Simurka P; Tamm E; Tešović G; Urbančíková I; Usonis V; Wysocki J; Zavadska D; Central European Vaccination Awareness Group
    Expert Rev Vaccines; 2014 Jun; 13(6):801-15. PubMed ID: 24655008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mission Indradhanush and the counterfeit drug trade in India.
    Banerjee Y
    Lancet Infect Dis; 2015 Dec; 15(12):1379-80. PubMed ID: 26607123
    [No Abstract]   [Full Text] [Related]  

  • 17. Foreword.
    Etienne CF
    Vaccine; 2015 May; 33 Suppl 1():A1. PubMed ID: 25919148
    [No Abstract]   [Full Text] [Related]  

  • 18. The ProVac initiative and evolving decision support.
    Sanderson CF
    Vaccine; 2015 May; 33 Suppl 1():A8-10. PubMed ID: 25919181
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
    Molina-Aguilera IB
    Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
    [No Abstract]   [Full Text] [Related]  

  • 20. Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2013.
    Hull B;
    Commun Dis Intell Q Rep; 2014 Mar; 38(1):E85-6. PubMed ID: 25409360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.